Indian equity benchmarks end little changed as traders weigh BoJ decision and key technical levels

Indian equity benchmarks ended almost unchanged on December 18 after a volatile session, as traders avoided big bets ahead of the Bank of Japan policy decision on December 19. The Sensex slipped 77.84 points to 84,481.81, while the Nifty eased 3 points to 25,815.55. Market participants also tracked global macro data, FII flows and INR/USD moves.

Broader indices outperformed the benchmarks, with the midcap index gaining 0.34 percent and the small-cap index edging up 0.13 percent, suggesting continued interest beyond large caps. Volatility stayed muted, as the India VIX fell 1.32 percent to 9.70, hinting at expectations of range-bound trade and some complacency in risk assessment.

Technical levels on the Nifty stayed in focus after the benchmark held above a key support area. Market strategists noted that traders are dealing with choppy price action and no strong domestic trigger. This has pushed many participants towards a stock-specific approach, with tighter risk controls and cautious position sizing across sectors and time frames.

"From a technical perspective, the Nifty has managed to hold the crucial support near the previous swing low around 25,700, which remains a key level to monitor in the coming session, as a breakdown could lead to further correction. On the upside, the short-term moving average, the 20-DEMA, continues to act as an immediate hurdle around 25,950, and a sustained move above this level will be essential for the next leg of the up move. Given the prevailing choppiness and absence of strong triggers, stock-specific trading approach remains advisable, with an emphasis on disciplined risk management and controlled position sizing," commented Ajit Mishra - SVP, Research, Religare Broking Ltd.

Bank Nifty action drew close attention, as the index signalled weakness on the daily chart. Analysts highlighted important support and resistance bands that may guide intraday and short-term decisions. The price pattern suggested that financial stocks could face pressure if critical levels give way, especially with global central bank events on the radar.

"Technically, on the daily chart, Bank Nifty formed a red candle, indicating weakness. On the downside, 58,800-58,900 will act as an immediate support zone for Bank Nifty, and a firm break below 58,800 could extend the weakness towards the 58,500-58,000 levels. On the upside, 60,000-60,120 will act as a stiff resistance zone for the index. Therefore, short-term traders are advised to book profits on every bounce.", according to Hrishikesh Yedve, AVP Technical and Derivative Research, Asit C. Mehta Investment Interrmediates Ltd.

While index moves stayed muted, some analysts pointed to selective opportunities in the cash market. As investors awaited the start of the Bank of Japan's two-day meeting on December 19, attention turned to sectors and stocks showing relative strength. The central bank was widely expected to raise its policy rate from 0.5 percent to 0.75 percent on Friday, which could influence global risk sentiment.

Technical analyst Riyank Arora of Mehta Equities Ltd. recommended two stocks for traders on Friday, December 19, based on price structure and momentum indicators. Both names showed supportive setups on charts, with defined stop-loss levels and upside targets. The suggested ideas were from financial services and pharmaceuticals, two areas that have drawn steady interest in recent sessions.

The key trade levels for the recommended stocks are set out below for easy reference.

Stock	Action	CMP (Rs)	Stop-Loss (Rs)	Targets (Rs)
Manappuram Finance	Buy	287.05	275	300 / 312
Glenmark Pharma	Buy	1,957.10	1,900	2,020 / 2,080

Manappuram Finance was trading above a support area near Rs 275, which indicated buying interest on declines. The chart structure stayed constructive, with the RSI holding in a bullish band. A move above Rs 290 was seen as a trigger that could quicken upside momentum towards Rs 300 initially, and later near Rs 312, with a stop-loss at Rs 275.

Glenmark Pharma retained a strong upward pattern, backed by consistent demand at lower levels and trade above key moving averages. The RSI showed continued positive momentum, supporting the bullish setup. Analysts observed that a sustained break above Rs 1,980 could lift the stock towards Rs 2,020 first, and then to Rs 2,080, while traders were advised to maintain a stop-loss at Rs 1,900.

Index traders also weighed the implications of the low India VIX level of 9.70, which often reflects calm conditions but can also signal complacency. With global macro data and foreign investor flows in play, many market participants preferred measured exposure. The combination of firm broader indices and flat benchmarks suggested selective risk-taking rather than broad-based buying.

"The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred to as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions."

Overall, trade on December 18 showed cautious positioning in headline indices, firmer broader markets and clear technical reference points for Nifty and Bank Nifty. With the Bank of Japan meeting and a possible rate hike from 0.5 percent to 0.75 percent approaching, domestic traders continued to rely on chart levels and stock-specific ideas, while keeping risk management at the centre of their strategies.